| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |